Section Arrow
SRPT.NASDAQ
- Sarepta Therapeutics
Quotes are at least 15-min delayed:2025/09/12 04:14 EDT
Pre Market
Last
 17.8
-0.11 (-0.61%)
Bid
17.77
Ask
17.8
High 17.9 
Low 17.8 
Volume 1344 
Regular Hours
Last
 17.91
+0.69 (+4.01%)
Day High 
17.95 
Prev. Close
17.22 
1-M High
22.09 
Volume 
6.13M 
Bid
17.77
Ask
17.8
Day Low
16.85 
Open
17.2 
1-M Low
17.2 
Market Cap 
1.80B 
Currency USD 
P/E 15.76 
%Yield -- 
10-SMA 18.14 
20-SMA 19.11 
50-SMA 17.76 
52-W High 138.81 
52-W Low 10.415 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.68/2.48
Enterprise Value
3.13B
Balance Sheet
Book Value Per Share
12.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.03M
Operating Revenue Per Share
10.56
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GRIGRI Bio Inc.2.05+0.49+31.41%0.02PE
Pre Market 1.78 -0.27 -13.17%
RXRXRecursion Pharmaceuticals4.85+0.31+6.83%-- 
Pre Market 4.93 +0.08 +1.65%
SLXNSilexion Therapeutics Corp4.93+0.445+9.92%-- 
Pre Market 4.92 -0.01 -0.20%
ADAPAdaptimmune Therapeutics plc0.0505-0.0003-0.59%-- 
Pre Market 0.0515 +0.001 +1.98%
ROIVRoivant Sciences Ltd14.41+0.64+4.65%1.95PE
Pre Market 14.41 0 0.00%
Quotes are at least 15-min delayed:2025/09/12 04:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.